Condition
Relapsed or Refractory Hematologic Malignancies clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Relapsed or Refractory Hematologic Malignancies clinical trials that are recruiting, at sites in 3 countries (most in China (2), Poland (1), United States (1)). By phase: Phase 1 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 3Countries
Newest Relapsed or Refractory Hematologic Malignancies clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| QLS2309 injections for adults with CD70-positive relapsed or refractory blood cancers. | Phase 1 | Beijing, Beijing Municipality | Recruiting | Sep 15, 2025 |
| Evaluating SCTC21C for patients with CD38+ blood cancers | Phase 1 | Beijing, Beijing Municipality | Recruiting | Feb 9, 2024 |
| Tolerability of trichostatin A for people with relapsed or refractory blood cancers | Phase 1 | Washington D.C., District of Columbia and 10 other locations | Recruiting | Feb 12, 2019 |
All recruiting trials (3)
-
QLS2309 injections for adults with CD70-positive relapsed or refractory blood cancers.
This trial will try QLS2309 injections to see if they are safe, tolerated, and show early anti-cancer effects in adults with CD70-positive relapsed or refractory blood cancers.
-
Evaluating SCTC21C for patients with CD38+ blood cancers
This study is testing a new treatment called SCTC21C to see if it can help people with certain types of blood cancers that have come back or didn’t respond to other treatments.
-
Tolerability of trichostatin A for people with relapsed or refractory blood cancers
This trial will test whether trichostatin A is safe and tolerable for adults whose blood cancers have come back or stopped responding to treatment.
Quick answers
How many Relapsed or Refractory Hematologic Malignancies clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Poland (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.